REDWOOD CITY, Calif., May 7, 2014 (GLOBE NEWSWIRE) -- California based myoscience, inc., makers of the revolutionary iovera° system for treatment of peripheral nerves, announced today it has been selected as a finalist for Red Herring's Top 100 North America award, a prestigious list honoring the year's most promising private technology ventures from the North American business region.
Red Herring has been selecting the most exciting and promising start-ups and "scale ups" since 1995. Finalists are still evaluated individually from a large pool of hundreds of candidates based across North America. Twenty major criteria underlie the scoring and process. The list of finalists often includes the best performing and prominent companies of that year.
"We are honored to be recognized as a finalist for this award," said myoscience CEO Clint Carnell. "I'm proud to see the efforts of our talented employees recognized. Their hard-work and dedication the past 9 years bringing this remarkable platform technology to the world will change the landscape of treating peripheral nerve conditions."
Myoscience's groundbreaking iovera° treatment harnesses the power of cold with the Focused Cold TherapyTM delivery system and delivers immediate results for both therapeutic and aesthetic applications. The iovera° treatment does not use toxins, chemicals, or pharmaceuticals to achieve results and leaves nothing behind in the body. The iovera° system is FDA cleared for the treatment of pain in the United States and is approved in the European Union and Canada for the treatment of wrinkles.
2014 will be remembered as a special vintage. "The finalists list confirms the excellent choices made by entrepreneurs and VCs and the start-ups' solid roots in corporate America, embracing their innovations. By all metrics, it emphasizes the United States' entrepreneurial excellence," said Alex Vieux, publisher and CEO of Red Herring.
Finalists are asked to present their winning strategies at the Red Herring North America Forum in Monterey, Calif., May 14 to 16, 2014. The Top 100 winners will be announced at a special awards ceremony the evening of May 16 at the event.
Please follow the Red Herring conference at https://twitter.com/digitalherring hashtag #RedHerring100
ABOUT MYOSCIENCE
Silicon Valley, California-based myoscience is a privately-held medical device company committed to making its platform technology, Focused Cold Therapy, the standard of care for the treatment of peripheral nerve conditions. Focused Cold Therapy is the patented technology delivered by the iovera° system. The iovera° system is currently approved in Europe and Canada for temporary wrinkle reduction, temporary pain reduction and treatment of dermatologic conditions, and is indicated in the United States for use in pain management and general surgical use. For more information, please visit www.myoscience.com.
The myoscience logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=13581
© 2014 myoscience. All rights reserved. iovera° and Focused Cold Therapy are trademarks of myoscience.